The Association and diagnostic value between Maternal Serum Placental Markers and Placenta Previa
Open Access
- 11 October 2024
- journal article
- research article
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology: X
- Vol. 24, 100346
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Association between human chorionic gonadotropin (hCG) levels and adverse pregnancy outcomes: A systematic review and meta-analysisPregnancy Hypertension, 2023
- Correlation between elevated maternal serum alpha-fetoprotein and ischemic placental disease: a retrospective cohort studyClinical and Experimental Hypertension, 2023
- Recurrence Rate for Isolated Elevated Maternal Serum Alpha-Fetoprotein Levels and Pregnancy OutcomesGenetic Testing and Molecular Biomarkers, 2022
- The predictive value of maternal serum AFP to PAPP-A or b-hCG ratios in spontaneous preterm birthJournal of Obstetrics and Gynaecology, 2022
- A risk model of prenatal screening markers in first trimester for predicting hypertensive disorders of pregnancyEPMA Journal, 2020
- Value of ultrasound scoring system for assessing risk of pernicious placenta previa with accreta spectrum disorders and poor pregnancy outcomesJournal of Medical Ultrasonics, 2019
- Successful resuscitation of a patient with pernicious placenta previa and placenta accreta who had massive life-threatening bleeding during cesarean sectionMedicine, 2019
- Impact of placenta previa with placenta accreta spectrum disorder on fetal growthUltrasound in Obstetrics & Gynecology, 2019
- Correction to: Farzad Mohajeri et. al., Ultrasound measurement of fetal adrenal gland in fetuses with intrauterine growth restriction, an early predictive method for adverse outcomesThe Journal of Maternal-Fetal & Neonatal Medicine, 2017
- Relationship between first trimester aneuploidy screening test serum analytes and placenta accretaThe Journal of Maternal-Fetal & Neonatal Medicine, 2017